GridAI Technologies (GRDX) Shares Outstanding (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Shares Outstanding (Entity) came in at $1.6 million in Q4 2025, up 41.2% YoY from $1.1 million in Q4 2024, and down 2.18% on a QoQ basis from $1.7 million in Q3 2025.
GridAI Technologies (GRDX) Shares Outstanding (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Shares Outstanding (Entity) data on file, last reported at $1.6 million in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 41.2% year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (up 41.2% YoY) and the FY2025 annual result came in at $1.6 million, up 41.2% from the prior year.
- Shares Outstanding (Entity) fell to $1.6 million in Q4 2025, from $1.7 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $1.7 million in Q3 2025 to a low of $439.0 in Q1 2021.
- A 5-year average of $547373.8 and a median of $75062.0 in 2023 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) soared 3207.08% — and 2025, when it increased 4.56%.
- Tracing GRDX's Shares Outstanding (Entity) over 5 years: stood at $708.0 in 2021, then jumped by 1590.82% to $11971.0 in 2022, then soared by 836.54% to $112113.0 in 2023, then surged by 921.26% to $1.1 million in 2024, then surged by 41.2% to $1.6 million in 2025.
- The last three Shares Outstanding (Entity) figures came in at $1.6 million (Q4 2025), $1.7 million (Q3 2025), and $1.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - | 1.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.62 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 1.59 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 764,728.00 |
| Mar 31, 2024 | 587,312.00 |
| Dec 31, 2023 | 112,113.00 |
| Sep 30, 2023 | 126,099.00 |
| Jun 30, 2023 | 37,848.00 |
| Mar 31, 2023 | 38,011.00 |
| Dec 31, 2022 | 11,971.00 |
| Sep 30, 2022 | 3,813.00 |
| Jun 30, 2022 | 1,731.00 |
| Mar 31, 2022 | 1,234.00 |
| Dec 31, 2021 | 708.00 |
| Sep 30, 2021 | 741.00 |
| Jun 30, 2021 | 620.00 |
| Mar 31, 2021 | 439.00 |